Beyond Air (XAIR) Stock Overview

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

XAIR Stock Information

Symbol

XAIR

Address

900 Stewart AvenueGarden City, NY 11530United States

Founded

Trading hours

Website

https://www.beyondair.net

Country

🇺🇸 United States

Phone Number

516 665 8200

Beyond Air (XAIR) Price Chart

Beyond Air Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.4101	N/A
Market Cap	$12.29M	N/A
Shares Outstanding	29.97M	16.77%
Employees	98.00	N/A
Shareholder Equity	42.03M	-46.26%

Valuation	2023	Change
P/E Ratio	-0.22	N/A
P/B Ratio	0.29	N/A

Growth	2023	Change
Return on Equity	-1.4134	N/A

Earnings	2023	Change
Revenue	$0	N/A
Earnings	-$59.40M	N/A
EPS	-1.86	N/A
Earnings Yield	-4.54	N/A

Financial Strength	2023	Change
Total Assets	$68.75M	N/A
Total Debt	$3.59M	N/A
Cash on Hand	$45.88M	N/A
Debt to Equity	0.6358	136.90%
Cash to Debt	$12.77	-44.49%
Current Ratio	$3.00	-65.38%